COVID-19 Vaccine Results A Breakthrough Moment For BioNTech

Founder Considers Its Focus To Be Immunotherapy, Not mRNA

 
• By Andrew McConaghie
  
Stafford / United Kingdom - November 9 2020: Pfizer BioNTech Covid-19 vaccine concept. Syringe balanced on a fingertip and blurred company logos on the background. Selective focus.
BNT162b1 may become known as the 'Pfizer vaccine' but BioNTech will be transformed by its likely success.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip